*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Clinical Trial Regulations of Personalized Medicine

Author: TEENA SHERIN M, ARUN RADHAKRISHNAN
Abstract: Personalized medicine is a clinical model that isolates individuals into various groups with clinical choices, practices, intercessions and additionally items being customized to the individual patient dependent on their anticipated reaction or danger of disease. The utilization of genetic data has assumed a significant part in personalized medicine (e g pharmacogenomics). Modern advances in personalized medicine depend on innovation that affirms a patient's major DNA, RNA, biology or protein, which at last prompts confirming disease. The ideas of personalized medication can be applied to new and extraordinary ways to deal with medical services. The history of personalized medicine is clearly discussed in this article. And with that, literature review on various type of clinical trial was done. The two types of clinical trials are conventional clinical trial and differential clinical trial. The conventional clinical trial is a regular trial in which simple drugs are evaluated and the study can be done by observing all the phases. But in the case of differential clinical trial, the clinical trial is been carried out on complicated diseases and personalized medicines, where there are no proper regulatory guidelines to be followed. It is concluded that the advancing field of personalized medication is an emerging zone with a range of applications for rare diseases, which include actual advances in clinical trial outcomes for properly chosen patient sub-sets.
Keyword: personalized medicine, conventional clinical trials, differential clinical trials.
DOI: https://doi.org/10.31838/ijpr/2021.13.01.601
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free